MORORATE

This brand name is authorized in Nigeria.

Active ingredients

The drug MORORATE contains one active pharmaceutical ingredient (API):

1	Mometasone UNII 04201GDN4R - MOMETASONE FUROATE
	Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.
	Read more about Mometasone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101002	Cream	Mororate Cream_ (check strength) CREAM 1 mg 5 g ; 15 g (in collapsible aluminum tube)	White Cream. 61 NF-PP-413427 MORORATE CREAM MOMETASONE FUROATE 15G MOMETASONE FUROATE 0.1% (Excipients: Hexylene glycol , Titanium Dioxide, Aluminum Starch Octenylsuccinate, White Beeswax, White Soft Paraffin , Hydrogenated Soybean Lecithin , Phosphoric acid , Purified water) A4-101002 Drugs Imported Products 1X15G,1X5G POM 2 3/20/2024 AKSO PHARMACEUTICAL NIGERIA LIMITED, ODUSAMI STREET OFF WEMPCO ROAD OGBA IKEJA LAGOS 8180218332 506798052@qq.com Front Pharmaceuticals PLC, Xuancheng Economic and Technical Development Zone, anhui China, China	28/08/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07XC03	Mometasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XC Corticosteroids, potent, other combinations
Discover more medicines within D07XC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101002